123 related articles for article (PubMed ID: 21631268)
1. Characterization of CXCR4 expression in chondrosarcoma of bone.
Bai S; Wang D; Klein MJ; Siegal GP
Arch Pathol Lab Med; 2011 Jun; 135(6):753-8. PubMed ID: 21631268
[TBL] [Abstract][Full Text] [Related]
2. SDF-1/CXCR4 signaling up-regulates survivin to regulate human sacral chondrosarcoma cell cycle and epithelial-mesenchymal transition via ERK and PI3K/AKT pathway.
Yang P; Wang G; Huo H; Li Q; Zhao Y; Liu Y
Med Oncol; 2015 Jan; 32(1):377. PubMed ID: 25428386
[TBL] [Abstract][Full Text] [Related]
3. The utility of SATB2 immunohistochemical expression in distinguishing between osteosarcomas and their malignant bone tumor mimickers, such as Ewing sarcomas and chondrosarcomas.
Machado I; Navarro S; Picci P; Llombart-Bosch A
Pathol Res Pract; 2016 Sep; 212(9):811-6. PubMed ID: 27465835
[TBL] [Abstract][Full Text] [Related]
4. [Significance of expression of stromal cell derived factor 1 and CXCR4 in invasive breast cancer].
Liu FF; Wei J; Lang RG; Fan Y; Cui LF; Gu F; Fu L
Zhonghua Bing Li Xue Za Zhi; 2008 Aug; 37(8):529-35. PubMed ID: 19094464
[TBL] [Abstract][Full Text] [Related]
5. KPNA2 expression is a potential marker for differential diagnosis between osteosarcomas and other malignant bone tumor mimics.
Jiang L; Liu J; Wei Q; Wang Y
Diagn Pathol; 2020 Nov; 15(1):135. PubMed ID: 33176814
[TBL] [Abstract][Full Text] [Related]
6. Stromal cell derived factor-1 and CXCR4 expression in colorectal cancer promote liver metastasis.
Amara S; Chaar I; Khiari M; Ounissi D; Weslati M; Boughriba R; Hmida AB; Bouraoui S
Cancer Biomark; 2015; 15(6):869-79. PubMed ID: 26406413
[TBL] [Abstract][Full Text] [Related]
7. Involvement of chemokine receptor 4/stromal cell-derived factor 1 system during osteosarcoma tumor progression.
Perissinotto E; Cavalloni G; Leone F; Fonsato V; Mitola S; Grignani G; Surrenti N; Sangiolo D; Bussolino F; Piacibello W; Aglietta M
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):490-7. PubMed ID: 15701832
[TBL] [Abstract][Full Text] [Related]
8. Expression of CXCR4 and MMP-2 is associated with poor prognosis in patients with osteosarcoma.
Gong C; Sun K; Xiong HH; Sneh T; Zhang J; Zhou X; Yan P; Wang JH
Histol Histopathol; 2020 Aug; 35(8):863-870. PubMed ID: 32314796
[TBL] [Abstract][Full Text] [Related]
9. Expression of stromal derived factor-1 (SDF-1) and chemokine receptor (CXCR4) in bone metastasis of renal carcinoma.
Zhao FL; Guo W
Mol Biol Rep; 2011 Feb; 38(2):1039-45. PubMed ID: 20563655
[TBL] [Abstract][Full Text] [Related]
10. miR-181a Targets RGS16 to Promote Chondrosarcoma Growth, Angiogenesis, and Metastasis.
Sun X; Charbonneau C; Wei L; Chen Q; Terek RM
Mol Cancer Res; 2015 Sep; 13(9):1347-57. PubMed ID: 26013170
[TBL] [Abstract][Full Text] [Related]
11. Expression of insulin-like growth factor II mRNA binding protein 3 (IMP3) in enchondroma and chondrosarcoma.
Shooshtarizadeh T; Nazeri A; Zare-Mirzaie A; Movahedinia S
Pathol Res Pract; 2016 Apr; 212(4):335-9. PubMed ID: 26948096
[TBL] [Abstract][Full Text] [Related]
12. Relationships between levels of CXCR4 and VEGF and blood-borne metastasis and survival in patients with osteosarcoma.
Lin F; Zheng SE; Shen Z; Tang LN; Chen P; Sun YJ; Zhao H; Yao Y
Med Oncol; 2011 Jun; 28(2):649-53. PubMed ID: 20349215
[TBL] [Abstract][Full Text] [Related]
13. Expression pattern of CXC chemokine receptor-4 is correlated with lymph node metastasis in human invasive ductal carcinoma.
Kato M; Kitayama J; Kazama S; Nagawa H
Breast Cancer Res; 2003; 5(5):R144-50. PubMed ID: 12927045
[TBL] [Abstract][Full Text] [Related]
14. Endogenous secretory receptor for advanced glycation endproducts as a novel prognostic marker in chondrosarcoma.
Takeuchi A; Yamamoto Y; Tsuneyama K; Cheng C; Yonekura H; Watanabe T; Shimizu K; Tomita K; Yamamoto H; Tsuchiya H
Cancer; 2007 Jun; 109(12):2532-40. PubMed ID: 17497647
[TBL] [Abstract][Full Text] [Related]
15. Association of CXC chemokine receptor type 4 expression and clinicopathologic features in human vulvar cancer.
Shiozaki T; Tabata T; Ma N; Yamawaki T; Motohashi T; Kondo E; Tanida K; Okugawa T; Ikeda T
Int J Gynecol Cancer; 2013 Jul; 23(6):1111-7. PubMed ID: 23765204
[TBL] [Abstract][Full Text] [Related]
16. Galectin-1 is a powerful marker to distinguish chondroblastic osteosarcoma and conventional chondrosarcoma.
Gomez-Brouchet A; Mourcin F; Gourraud PA; Bouvier C; De Pinieux G; Le Guelec S; Brousset P; Delisle MB; Schiff C
Hum Pathol; 2010 Sep; 41(9):1220-30. PubMed ID: 20399482
[TBL] [Abstract][Full Text] [Related]
17. [The expression and significance of trefoil factor 3 and SDF-1/CXCR4 biological axis in papillary thyroid carcinoma].
Xue G; Huang J; Zhang H; Zhang W; Wu J; Shang X
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Jan; 28(2):108-12. PubMed ID: 24738314
[TBL] [Abstract][Full Text] [Related]
18. CXCR4 expression in neuroblastoma primary tumors is associated with clinical presentation of bone and bone marrow metastases.
Russell HV; Hicks J; Okcu MF; Nuchtern JG
J Pediatr Surg; 2004 Oct; 39(10):1506-11. PubMed ID: 15486895
[TBL] [Abstract][Full Text] [Related]
19. Expression of c-met proto-oncogene product (c-MET) in benign and malignant bone tumors.
Naka T; Iwamoto Y; Shinohara N; Ushijima M; Chuman H; Tsuneyoshi M
Mod Pathol; 1997 Aug; 10(8):832-8. PubMed ID: 9267827
[TBL] [Abstract][Full Text] [Related]
20. The clinical pathological significance of FRAT1 and ROR2 expression in cartilage tumors.
He L; Yang Z; Zhou J; Wang W
Clin Transl Oncol; 2015 Jun; 17(6):438-45. PubMed ID: 25387569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]